Abstract
The present invention relates to microbial production of the sweet non-calorigenic sesquiterpenoid hernandulcin. Disclosed herein are yeast cells capable of producing hernandulcin and optionally hernandulcin derivatives, said yeast cells expressing at least one (+)-epi-alpha-bisabolol synthase, at least one cytochrome P450 enzyme (CYP) and at least one cytochrome P450 reductase, preferably said CYP the Nicotiana tabacum CYP 5-epi-aristolocene dihydroxylase (NtEAH) or the Datura stramonium cytochrome P450 enzyme DsEAH.
| Original language | English |
|---|---|
| IPC | C12P 5/ 00 A I |
| Patent number | WO2023242403 |
| Filing date | 16/06/2022 |
| Country/Territory | International Bureau of the World Intellectual Property Organization (WIPO) |
| Priority date | 16/06/2022 |
| Priority number | EP20220179430 |
| Publication status | Published - 21 Dec 2023 |
Fingerprint
Dive into the research topics of 'Microbial cells and methods for production of hernandulcin'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver